In today's increasingly popular assisted reproductive technology, can future babies have healthier bodies through scientific means?

In Kyrgyzstan, with the help of mature in vitro fertilization and assisted reproductive technology, genetic screening has become an important part of eugenics.

Many families hope to use this technology to avoid genetic risks and provide a good starting point for new life.

So, how does genetic screening work? Can it really 'optimize' offspring? This article will reveal the scientific truth behind it to you by the Tulip International Reproductive Center.

Q1: What is pre implantation genetic testing (PGT)? How does it screen high-quality embryos?

PGT, also known as pre implantation genetic testing, is the core of third-generation IVF technology. Its main purpose is to analyze the genetic material of embryos before transferring them back to the uterus, in order to select embryos with normal chromosome numbers and without carrying specific pathogenic genes for transplantation.

The specific operation process is as follows:

In vitro fertilization and embryo culture: In a laboratory environment, sperm are combined with eggs to cultivate fertilized eggs.

Embryo culture: Cultivate embryos until day 5 or 6 to develop into blastocysts. The blastocyst contains hundreds of cells and has a more stable structure.

Biopsy sampling: Embryologists use microscopic techniques to extract a small amount of cells from the trophoblast layer of the blastocyst (the part that will develop into the placenta in the future). This process avoids the inner cell mass (the part that will develop into a fetus in the future), so it will not cause damage to the growth and development of the fetus.

Gene sequencing and analysis: DNA amplification and sequencing are performed on extracted cells to analyze whether their chromosome structure and number are normal, or whether they carry specific genetic pathogenic genes.

Transplantation decision: Doctors prioritize selecting embryos with normal test results for transplantation based on the test report, in order to improve clinical pregnancy rates and reduce the risk of miscarriage.

Q2: How can genetic screening reduce the risk of miscarriage and block genetic diseases?

The root cause of many natural miscarriages and repeated implantation failures is ultimately chromosomal abnormalities in the embryo itself.

The harm of chromosomal aneuploidy: The human body normally has 23 pairs of chromosomes. If the number of chromosomes in an embryo increases or decreases (non diploid), it often leads to embryonic arrest, natural miscarriage, or birth defects. For example, the trisomy on chromosome 21 can cause Down syndrome, and the trisomy on chromosome 18 can cause Edwards syndrome.

The clinical value of PGT technology: Through PGT-A (chromosome aneuploidy screening), the laboratory team at Tulip International Reproductive Center can identify embryos with normal chromosomes. Clinical data shows that transferring whole ploidy embryos screened by PGT can significantly reduce early miscarriage rates and improve the success rate of implantation in a single transfer, which is particularly important for elderly women or patients with a history of recurrent miscarriage.

Blocking monogenic genetic diseases: For couples carrying specific monogenic genetic diseases (such as thalassemia, hemophilia, cystic fibrosis, etc.), PGT-M (monogenic disease detection) technology can accurately identify whether the embryo carries pathogenic mutations, thereby blocking the transmission of pathogenic genes in the family and achieving eugenics.

Q3: What are the advantages of assisted reproductive technology in Kyrgyzstan? How does the Tulip International Reproductive Center ensure a success rate?

In recent years, Kyrgyzstan has become a popular choice for many international families seeking assisted reproductive services due to its sound laws and regulations and cost-effective medical services.

1. Environmentally friendly legal policies

Kyrgyzstan's laws explicitly protect the legality of assisted reproductive practices, allowing for gender screening (for reasonable needs such as family balance) and genetic testing through medical means. This relaxed and regulated legal environment provides doctors and patients with a broader range of medical options to choose from.

2. Application of cutting-edge technologies

The Tulip International Reproductive Center has introduced international high standard NGS (high-throughput sequencing) technology. Compared to traditional detection methods, NGS has higher resolution and accuracy, and can detect even smaller chromosomal abnormalities. In addition, the center combines big data analysis systems to assist doctors in evaluating the developmental potential of embryos, and comprehensively scores them from both morphological and genetic dimensions, further improving the success rate of transplantation.

3. Comprehensive medical plan

In addition to genetic technology, the center also focuses on personalized ovulation induction programs and uterine environment management for expectant mothers, ensuring that "high-quality seeds" are nurtured through "fertile soil" and comprehensively guaranteeing the health of mother and baby.

Q4: What are the real cases of assisted reproduction? How genetic screening can change family destiny?

To provide a more intuitive understanding of this technology, we share a real-life case that occurred at the Tulip International Reproductive Center.

Background of the case: Mr. Li (pseudonym) and his wife from East Asia have a serious history of X-linked inheritance in their family. Although Mrs. Li is in good health, as a carrier of the disease causing gene, there is a 50% chance that boys born to her have the disease, and a 50% chance that girls will become carriers. The couple had previously experienced a painful induced abortion because prenatal diagnosis revealed that the fetus had the genetic disease.

Solution: After multiple investigations, Mr. and Mrs. Li chose the Tulip International Reproductive Center in Kyrgyzstan. The medical team has developed a third-generation IVF (PGT-M) protocol for them.

Treatment process:

The doctor obtained 12 mature eggs and successfully cultivated 6 blastocysts through a scientific ovulation induction program.

Through PGT-M technology, the laboratory conducted targeted genetic testing on these 6 blastocysts.

The test results showed that 2 blastocysts were diseased, 2 were carriers, and 2 were completely healthy with normal chromosomes.

The doctor chose a completely healthy and chromosome normal blastocyst and transplanted it into the uterus of a caring assisted mother.

After undergoing strict physical examinations and endometrial conditioning, the assisted mother's physical condition is excellent. On the 12th day after transplantation, a blood test was conducted to successfully conceive, and a healthy male baby was successfully delivered at full term. Through genetic screening, this family not only has healthy children, but also completely blocks the transmission of hereditary diseases in the family.

Q5: Is gene editing the future or a forbidden zone?

With the development of technology, there are not only more discussions about "screening", but also about "modifying" genes. For example, CRISPR gene editing technology can theoretically modify DNA fragments.

The boundary between science and ethics: Current assisted reproductive technologies (including PGT) focus on "discovering" and "screening" naturally occurring healthy embryos, rather than "manufacturing" or "editing" genes.

Although gene editing has shown potential in treating genetic diseases at the laboratory level, the global medical community (including Kyrgyzstan) holds a very cautious attitude towards its clinical application. The main reasons include:

Off target effect risk: The editing process may accidentally damage other normal genes, bringing unpredictable health risks.

Multi gene complexity: Features such as height and intelligence are determined by hundreds or thousands of genes, and are deeply influenced by the environment. Currently, it is not possible to "customize" them through simple genetic manipulation.

Tulip International Reproductive Center always adheres to the bottom line of medical ethics and is committed to using mature and safe PGT screening technology to help families avoid disease risks.

Genetic screening technology has brought revolutionary progress to modern assisted reproduction, making eugenics no longer just talk. In Kyrgyzstan, Tulip International Reproductive Center has helped countless families achieve their dream of having a healthy baby through compliant and scientific means. The original intention of technology is to reduce pain and disease. Choosing a legitimate medical institution and making reasonable use of genetic screening technology are important steps towards a happy family.

For fertility consultation in Kyrgyzstan, please contact your dedicated consultant

/Fertility Consultation /

Dr.Chan

Copy and add: Tulip_EnoChan

Or long press/scan the QR code to add

Tulip International Fertility Center

Technology aids fertility, fulfilling dreams for countless families